Terumo Corporation - Company Research Report
Company Overview
Name: Terumo Corporation
Mission: Terumo is dedicated to "Contributing to Society Through Healthcare" by providing valued products and services in the healthcare market, addressing the needs of patients and healthcare professionals worldwide.
Founded: 1921
Founder: Dr. Shibasaburo Kitasato
Key People in the Company:
- Toshiaki Takagi, Chairman of the Board
- Hikaru Samejima, President and Chief Executive Officer
Headquarters:
- Global: Tokyo, Japan (2-44-1 Hatagaya, Shibuya-ku, Tokyo, 151-0072)
- North America: Somerset, NJ, United States (265 Davidson Avenue, Somerset, NJ 08873)
Number of Employees: 30,591 (Consolidated)
Revenue: 921.9 billion yen (for Fiscal Year Ending March 2024)
Reputation: Known as one of the world’s leading manufacturers of medical devices and supplies, Terumo is renowned for its commitment to developing, manufacturing, marketing, distributing, and selling high-quality medical devices and solutions.
Products
Terumo Corporation’s extensive product portfolio spans multiple areas in the healthcare sector, structured around the following divisions:
Terumo Interventional Systems (TIS)
Provides solutions for minimally invasive entry site management and lesion access for cardiology, peripheral arterial disease, embolotherapy, and interventional oncology.
Key Products Include:
- ANGIO-SEAL® VIP Vascular Closure Device
- AZUR® and AZUR HydroPack™ Peripheral Coil Systems
- GLIDESHEATH SLENDER® Introducer Sheath
Terumo Medical Products (TMP)
Focuses on devices for injection and infusion therapy for both human and veterinary markets.
Key Products Include:
- Hypodermic Needles and Syringes
- SurFlash® Polyurethane I.V. Catheters
- SurGuard® Safety Hypodermic Needles and Syringes
Pharmaceutical Solutions Division (PSD)
Offers comprehensive product design and development services to the pharmaceutical and medical device industries.
Key Products Include:
- PLAJEX™ Ready-to-Fill Polymer Syringes
- K-Pack™ Needles
Terumo Health Outcomes (THO)
Partners with healthcare providers to enhance patient outcomes and operational efficiencies with precision medicine software.
Key Features:
- ePRISM® Precision Medicine Software Platform
Recent Developments
Recent Developments:
- Manufacturing Expansion: Terumo Medical Corporation has commenced the construction of a new manufacturing site in Puerto Rico, indicating an expansion to meet growing demand.
- Product Launches:
- Launched AZUR HydroPack™ Peripheral Coil System, which provides a soft-packing, long-lasting solution to embolotherapy.
- Sustainability Initiatives:
- Terumo has set ambitious greenhouse gas reduction targets approved by the Science-Based Targets initiative as aligned with a 1.5°C climate goal.
- Clinical Innovations:
- New studies and prospective registries are reinforcing the efficacy and safety of Terumo’s medical solutions, including in interventional procedures such as the Cross-Seal™ Suture-Mediated Vascular Closure Device System.
- Events and Engagements:
- Participation in numerous industry events including VEITH and SCAI Fall Fellows, reflecting Terumo’s active engagement in industry dialogues.
Partnerships and Collaborations
- Integrated Healthcare Solutions: Terumo has continued to partner with clinicians and hospitals via the Terumo Health Outcomes division to optimize healthcare delivery.
- Commitment to ESG: Recognized as a constituent of the MSCI Japan ESG Select Leaders Index, demonstrating leadership in corporate responsibility initiatives including human rights, labor practices, and environmental stewardship.
This report provides a snapshot of Terumo Corporation’s foundational details, product offerings, and the latest strides it is making within the healthcare industry. For further information, visit their official website or reach out through their stated contact points.
